BSE: AUROPHARMA - Aurobindo Pharma Limited

Altı ay boyunca karlılık: -26.84%
Temettü getirisi: 0.00%

Promosyon programı Aurobindo Pharma Limited

Gelişmiş program Basit grafik
Financial Markets by TradingView

Şirket hakkında Aurobindo Pharma Limited

Aurobindo Pharma Limited, a biopharmaceutical company, engages in the manufacture of generic formulations and active pharmaceutical ingredients in India, the United States of America, Europe, Puerto Rico, and internationally.

daha fazla ayrıntı
The company offers formulation in form of oral solids, liquids, injectables, and vaccines, as well as over-the-counter drugs; and active pharmaceutical ingredients (APIs), biosimilars, biocatalysts, peptides, and hormones targeting key therapeutic areas, including central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretroviral drugs for the people and children living with HIV; and provides project-based chemistry contract services that cover the clinical stage through to manufacturing and management of the entire drug lifecycle in the API space for sterile and non-sterile penicillin's, cephalosporins, penems, and non-beta lactams. The company was incorporated in 1986 and is headquartered in Hyderabad, India.
Karşılaştırma listesine ekle
İzleme listesine ekle
Portföye ekle
Fiyat bildirimi ekle

ISIN INE406A01037
Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 0.7306
Дивиденд ао 4.5
Сайт https://www.aurobindo.com
Цена ао 1157.1
Günlük fiyat değişimi: 0% (1082.55)
Haftalık fiyat değişimi: -1.15% (1095.1)
Aylık fiyat değişimi: -1.11% (1094.65)
3 ayda fiyat değişimi: -6.83% (1161.85)
Altı ayda fiyat değişimi: -26.84% (1479.8)
Yıllık fiyat değişimi: -0.4597% (1087.55)
3 yılda fiyat değişimi: +55.22% (697.45)
5 yılda fiyat değişimi: +111.68% (511.4)
Yılbaşından bu yana fiyat değişimi: -13.25% (1247.85)
Tüm parametreler

Hafife alma

İsim Anlam Seviye
P/S 2.08 7
P/BV 2 7
P/E 18.84 7
EV/EBITDA 7.61 9
Toplam: 6.88

Yeterlik

İsim Anlam Seviye
ROA, % 7.47 2
ROE, % 11.2 4
Toplam: 3.17

Temettüler

İsim Anlam Seviye
Div yield, % 0 0
DSI 0.7143 7.14
Toplam: 1.52

Görev

İsim Anlam Seviye
Debt/EBITDA 1.58 7
Toplam: 8.4

Büyüme dürtüsü

İsim Anlam Seviye
karlılık Revenue, % 26.24 4
karlılık Ebitda, % 2.24 1
karlılık EPS, % 12.08 2
Toplam: 1.8
Daha fazla ayrıntı

Süpervizör İş unvanı Ödeme Doğum yılı
Mr. Mettu Madan Mohan Reddy Whole-Time Director 52.35M 1960 (65 yıllar)
Mr. Santhanam Subramanian Chief Financial Officer 21.06M 1961 (64 yıl)
Mr. Sanjeev Indravadan Dani COO & Head of Formulations N/A 1960 (65 yıllar)
Dr. S. Vijaya Kumar President of Technical N/A 1966 (59 yıllar)
Mr. Arvind Bothra Head of Investor Relations & Corporate Communications N/A
Mr. B. Adi Reddy Compliance Officer & Company Secretary 4.76M
Mr. G. P. Prasad Senior Vice President of Global Finance & Operations N/A
Dr. Sudhir Bimal Singhi Head of Global Finance Operations N/A 1969 (56 yıllar)
Mr. Kambam Nithyananda Reddy Vice Chairman & MD 1958 (67 yıllar)
Dr. Makkapati Satakarni B.E., M.B.A., Ph.D. President of Biologics, CEO of Biologics, Vaccines and Peptid & Director 1981 (44 yıl)

Adres: India, Hyderabad, Galaxy Plot No. 1 - Google haritalarda aç, Yandex haritalarını aç
Web sitesi: https://www.aurobindo.com